CD274 and cancer: Inhibition of the Pin1 simultaneously blocks multiple cancer pathways, disrupts the immunosuppressive TME and upregulates the expression of PD-L1 and gemcitabine transporter ENT1, thus benefiting PDAC patients undergoing immunochemotherapy [241].